Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival

Journal of Clinical Oncology

Volumn 21, Issue 17, 2003, Pages 3244-3248

  Woodward, Wendy A ^a   Strom, Eric A ^a   Tucker, Susan L ^a   McNeese, Marsha D ^a   Perkins, George H ^a   Schechter, Naomi R ^a   Singletary, S Eva ^a   Theriault, Richard L ^a   Hortobagyi, Gabriel N ^a   Hunt, Kelly K ^a   Buchholz, Thomas A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; HUMAN; MASTECTOMY; MEDICAL RECORD; MEDICAL SOCIETY; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; ARTICLE; BREAST TUMOR; FEMALE; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; STANDARD; SURVIVAL; UNITED STATES;

BREAST NEOPLASMS; FEMALE; HUMANS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UNITED STATES;

EID: 0141799967     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.03.052     Document Type: Review

References (11)

1. Singletary SE, Allred C, Ashley P, et al: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20:3628-3636, 2002
2. Blumenschein GR, Buzdar AU, Hortobagyi GN: FAC + BCG as adjuvant therapy in breast cancer: An 8-year update. Recent Results Cancer Res 96:129-132, 1984
3. Buzdar AU, Blumenschein GR, Smith TL, et al: Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer: A prospective randomized trial. Cancer 53:384-389, 1984
4. Buzdar AU, Hortobagyi GN, Marcus CE, et al: Results of adjuvant chemotherapy trials in breast cancer at M.D. Anderson Hospital and Tumor Institute. NCI Monogr 81-85, 1986
5. Buzdar AU, Hortobagyi GN, Smith TL, et al: Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs. Cancer 62:2098-2104, 1988
6. Buzdar AU, Hortobagyi GN: Ten-year results of FAC adjuvant chemotherapy trial in breast cancer. Breast Cancer Res Treat 13:117-121, 1989
7. Buzdar AU, Sahin AA, Ross MA: Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancer. Ann Intern Med 117:771-777, 1992
8. Theriault R, AU B, GN H: Irradiation (XRT) following mastectomy in patients treated with FAC adjuvant therapy: M.D. Anderson Cancer Center experience. Proc Am Soc Clin Oncol 17, 1998 (abstr)
9. Harris E, Albert A: Survivorship Analysis for Clinical Studies. New York, NY, Dekker, 1991
10. Feinstein AR, Sosin DM, Wells CK: The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312:1604-1608, 1985
11. Bunnell CA, Winer EP: Lumping versus splitting: The splitters take this round. J Clin Oncol 20:3576-3577, 2002